1CM
REGN icon

1492 Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

1492 Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-243
Closed -$255K – 120
2024
Q3 		$255K Sell
243
-5
-2% -$5.56K 0.13% 77
2024
Q2 		$261K Buy
248
+23
+10% +$22.3K 0.15% 72
2024
Q1 		$217K Sell
225
-13
-5% -$12.4K 0.12% 86
2023
Q4 		$209K Sell
238
-11
-4% -$9.06K 0.12% 93
2023
Q3 		$205K Buy
+249
New +$196K 0.13% 86
2023
Q2 		– Sell
-249
Closed -$205K – 115
2023
Q1 		$205K Buy
+249
New +$188K 0.13% 93
2022
Q4 		– Sell
-301
Closed -$207K – 120
2022
Q3 		$207K Buy
+301
New +$189K 0.15% 94

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return